MoneyWorks4Me

Viyash Scientific - Quaterly Results

12 Aug 2026 Evaluate
The June 2026 quarter revenue stood at Rs. 3536.90 millions, up 7.77% as compared to Rs. 3281.80 millions during the corresponding quarter last year.A humble growth in net profit of 20.92% reported in the quarter ended June 2026 to Rs. 209.20  millions from Rs. 173.00 millions.A decline of 617.40 millions was observed in the OP in the quarter ended June 2026 from 623.50 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 3536.90 3281.80 7.77 3536.90 3281.80 7.77 13820.60 13103.40 5.47
Other Income 145.90 129.00 13.10 145.90 129.00 13.10 662.60 722.10 -8.24
PBIDT 617.40 623.50 -0.98 617.40 623.50 -0.98 3007.90 2805.00 7.23
Interest 14.40 60.20 -76.08 14.40 60.20 -76.08 162.10 251.40 -35.52
PBDT 603.00 550.80 9.48 603.00 550.80 9.48 2403.70 1738.90 38.23
Depreciation 324.10 308.90 4.92 324.10 308.90 4.92 1241.50 1247.20 -0.46
PBT 278.90 241.90 15.30 278.90 241.90 15.30 1162.20 491.70 136.36
TAX 69.70 68.90 1.16 69.70 68.90 1.16 403.50 -93.20 -532.94
Deferred Tax 23.50 -43.20 -154.40 23.50 -43.20 -154.40 251.40 -490.10 -151.30
PAT 209.20 173.00 20.92 209.20 173.00 20.92 758.70 584.90 29.71
Equity 873.70 500.70 74.50 873.70 500.70 74.50 873.70 500.60 74.53
PBIDTM(%) 17.46 19.00 -8.12 17.46 19.00 -8.12 21.76 21.41 1.67

Viyash Scientific Share Price

260.80 -0.65 (-0.25%)
12-Aug-2026 12:06 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1932.70
Dr. Reddys Labs. 1200.00
Cipla 1465.00
Lupin 2251.00
Zydus Lifesciences 1193.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: